Role of residual liver volumetry and function in prediction of liver tolerability after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients: deriving a clinical decision support score
Abstract Background Transarterial chemoembolization (TACE) is the recommended treatment modality for non-resectable intermediate-stage hepatocellular carcinoma; however, this stage has wide variable levels of liver functions and tumor burden making a challenge as regards the tolerability of the func...
Main Authors: | Abdallah A. Elsawy, Mohamed Mahmoud Dawoud, Reda A. Elarabawy, Waleed S. Mohamed, Rasha Mahmoud Dawoud |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-08-01
|
Series: | The Egyptian Journal of Radiology and Nuclear Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s43055-020-00265-4 |
Similar Items
-
Single-session combined radiofrequency ablation and transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Mahmoud A. Dawoud, et al.
Published: (2017-12-01) -
Role of drug-eluting beads versus conventional transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Mahmoud Abu Elfadl, et al.
Published: (2019-01-01) -
RESULTS OF TRANSARTERIAL CHEMOEMBOLIZATION OF STOMACH CANCER METASTASES IN THE LIVER
by: D. T. Arybzhanov
Published: (2017-02-01) -
Transarterial chemoembolization for patients with metastatic uveal melanoma in the liver
by: B. I. Dolgushin, et al.
Published: (2016-09-01) -
Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy
by: Jang JH, et al.
Published: (2015-09-01)